BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee J. Novel combinational treatment of cisplatin with cyclophilin a inhibitors in human heptocellular carcinomas. Arch Pharm Res 2010;33:1401-9. [DOI: 10.1007/s12272-010-0914-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Theuerkorn M, Fischer G, Schiene-fischer C. Prolyl cis/trans isomerase signalling pathways in cancer. Current Opinion in Pharmacology 2011;11:281-7. [DOI: 10.1016/j.coph.2011.03.007] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 6.9] [Reference Citation Analysis]
2 Suo A, Zhang M, Yao Y, Zhang L, Huang C, Nan K, Zhang W. Proteome analysis of the effects of sorafenib on human hepatocellular carcinoma cell line HepG2. Med Oncol 2012;29:1827-36. [DOI: 10.1007/s12032-011-0013-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
3 Simón Serrano S, Tavecchio M, Grönberg A, Sime W, Jemaà M, Moss S, Gregory MA, Gallay P, Elmér E, Hansson MJ, Massoumi R. Novel Cyclophilin Inhibitor Decreases Cell Proliferation and Tumor Growth in Models of Hepatocellular Carcinoma. Cancers (Basel) 2021;13:3041. [PMID: 34207224 DOI: 10.3390/cancers13123041] [Reference Citation Analysis]
4 Cheng S, Luo M, Ding C, Peng C, Lv Z, Tong R, Xiao H, Xie H, Zhou L, Wu J, Zheng S. Downregulation of Peptidylprolyl isomerase A promotes cell death and enhances doxorubicin-induced apoptosis in hepatocellular carcinoma. Gene 2016;591:236-44. [PMID: 27397650 DOI: 10.1016/j.gene.2016.07.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
5 Naoumov NV. Cyclophilin inhibition as potential therapy for liver diseases. J Hepatol. 2014;61:1166-1174. [PMID: 25048953 DOI: 10.1016/j.jhep.2014.07.008] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 8.3] [Reference Citation Analysis]
6 Feng W, Xin Y, Xiao Y, Li W, Sun D. Cyclophilin A Enhances Cell Proliferation and Xenografted Tumor Growth of Early Gastric Cancer. Dig Dis Sci 2015;60:2700-11. [PMID: 26008617 DOI: 10.1007/s10620-015-3694-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
7 Devarajan N, Manjunathan R, Ganesan SK. Tumor hypoxia: The major culprit behind cisplatin resistance in cancer patients. Crit Rev Oncol Hematol 2021;162:103327. [PMID: 33862250 DOI: 10.1016/j.critrevonc.2021.103327] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Novoderezhkina EA, Zhivotovsky BD, Gogvadze VG. Induction of unspecific permeabilization of mitochondrial membrane and its role in cell death. Mol Biol 2016;50:43-58. [DOI: 10.1134/s0026893316010167] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
9 Wang D, Li Y, Cui P, Zhao Q, Tan BB, Zhang ZD, Liu Y, Jia N. Zerumbone induces gastric cancer cells apoptosis: Involving cyclophilin A. Biomed Pharmacother 2016;83:740-5. [PMID: 27479192 DOI: 10.1016/j.biopha.2016.07.034] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
10 Zhang H, Chen J, Liu F, Gao C, Wang X, Zhao T, Liu J, Gao S, Zhao X, Ren H, Hao J. CypA, a gene downstream of HIF-1α, promotes the development of PDAC. PLoS One 2014;9:e92824. [PMID: 24662981 DOI: 10.1371/journal.pone.0092824] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
11 Guidi F, Puglia M, Gabbiani C, Landini I, Gamberi T, Fregona D, Cinellu MA, Nobili S, Mini E, Bini L, Modesti PA, Modesti A, Messori L. 2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds. Mol BioSyst 2012;8:985-93. [DOI: 10.1039/c1mb05386h] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]